Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says
This article was originally published in The Tan Sheet
Executive Summary
Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision
You may also be interested in...
Martek Fiscal 2002 Sales Jump 144.7%; WIC Acceptance Aids Growth
Infant formulas fortified with Martek Biosciences' DHA and ARA fatty acids have been accepted by the WIC program in roughly 15 states, Chief Executive Officer Henry Linsert said in a Dec. 12 analysts call
Martek Fiscal 2002 Sales Jump 144.7%; WIC Acceptance Aids Growth
Infant formulas fortified with Martek Biosciences' DHA and ARA fatty acids have been accepted by the WIC program in roughly 15 states, Chief Executive Officer Henry Linsert said in a Dec. 12 analysts call
Martek Fiscal 2002 Sales Jump 144.7%; WIC Acceptance Aids Growth
Infant formulas fortified with Martek Biosciences' DHA and ARA fatty acids have been accepted by the WIC program in roughly 15 states, Chief Executive Officer Henry Linsert said in a Dec. 12 analysts call